184 related articles for article (PubMed ID: 20663271)
1. A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks' duloxetine therapy.
Lai CH; Hsu YY
Int J Neuropsychopharmacol; 2011 Mar; 14(2):225-35. PubMed ID: 20663271
[TBL] [Abstract][Full Text] [Related]
2. Frontal regional homogeneity increased and temporal regional homogeneity decreased after remission of first-episode drug-naïve major depressive disorder with panic disorder patients under duloxetine therapy for 6 weeks.
Lai CH; Wu YT
J Affect Disord; 2012 Feb; 136(3):453-8. PubMed ID: 22137181
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine's modest short-term influences in subcortical structures of first episode drug-naïve patients with major depressive disorder and panic disorder.
Lai CH; Wu YT
Psychiatry Res; 2011 Nov; 194(2):157-62. PubMed ID: 21820879
[TBL] [Abstract][Full Text] [Related]
4. Increases in amplitude of low-frequency fluctuations in left fronto-parietal area after duloxetine therapy in first-episode, drug-naïve, major depressive disorder with panic disorder patients.
Lai CH
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E24-5. PubMed ID: 23037667
[No Abstract] [Full Text] [Related]
5. Duloxetine's effects in resting functional magnetic resonance imaging of first-episode, drug-naive major depressive disorder with panic disorder patients.
Lai CH
J Neuropsychiatry Clin Neurosci; 2011; 23(3):E10-1. PubMed ID: 21948903
[No Abstract] [Full Text] [Related]
6. First episode drug-naïve major depressive disorder with panic disorder: gray matter deficits in limbic and default network structures.
Lai CH; Hsu YY; Wu YT
Eur Neuropsychopharmacol; 2010 Oct; 20(10):676-82. PubMed ID: 20599363
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine-related growth of putamen and brainstem in first-onset drug-naive major depressive disorder with panic disorder: a case series.
Lai CH
J Neuropsychiatry Clin Neurosci; 2011; 23(2):E40-1. PubMed ID: 21677224
[No Abstract] [Full Text] [Related]
8. Duloxetine-induced subcortical growth in a patient with major depressive disorder and panic disorder.
Lai CH
J Neuropsychiatry Clin Neurosci; 2011; 23(2):E42-3. PubMed ID: 21677225
[No Abstract] [Full Text] [Related]
9. Duloxetine related effects of brain structure on a patient of major depressive disorder with panic disorder.
Lai CH
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):240-1. PubMed ID: 19833160
[No Abstract] [Full Text] [Related]
10. Duloxetine-modulating effects of brain structure in major depressive disorder with panic disorder.
Lai CH
J Clin Psychopharmacol; 2010 Feb; 30(1):88-9. PubMed ID: 20075662
[No Abstract] [Full Text] [Related]
11. The gray matter alterations in major depressive disorder and panic disorder: Putative differences in the pathogenesis.
Lai CH; Wu YT
J Affect Disord; 2015 Nov; 186():1-6. PubMed ID: 26208214
[TBL] [Abstract][Full Text] [Related]
12. Fronto-temporo-insula gray matter alterations of first-episode, drug-naïve and very late-onset panic disorder patients.
Lai CH; Wu YT
J Affect Disord; 2012 Nov; 140(3):285-91. PubMed ID: 22386047
[TBL] [Abstract][Full Text] [Related]
13. Increased anterior cingulate regional homogeneity after duloxetine therapy in first-episode, drug-naïve, major depressive disorder with panic disorder patients: a case series.
Lai CH
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E13-4. PubMed ID: 23037661
[No Abstract] [Full Text] [Related]
14. Improvements in white matter micro-structural integrity of right uncinate fasciculus and left fronto-occipital fasciculus of remitted first-episode medication-naïve panic disorder patients.
Lai CH; Wu YT; Yu PL; Yuan W
J Affect Disord; 2013 Sep; 150(2):330-6. PubMed ID: 23680435
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
16. Changes in gray matter volume of remitted first-episode, drug-naïve, panic disorder patients after 6-week antidepressant therapy.
Lai CH; Wu YT
J Psychiatr Res; 2013 Jan; 47(1):122-7. PubMed ID: 23079534
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
Raskin J; Wiltse CG; Siegal A; Sheikh J; Xu J; Dinkel JJ; Rotz BT; Mohs RC
Am J Psychiatry; 2007 Jun; 164(6):900-9. PubMed ID: 17541049
[TBL] [Abstract][Full Text] [Related]
18. Disturbed grey matter coupling in schizophrenia.
Collin G; de Reus MA; Cahn W; Hulshoff Pol HE; Kahn RS; van den Heuvel MP
Eur Neuropsychopharmacol; 2013 Jan; 23(1):46-54. PubMed ID: 23036782
[TBL] [Abstract][Full Text] [Related]
19. Grey matter volume abnormalities in the first depressive episode of medication-naïve adult individuals: a systematic review of voxel based morphometric studies.
Amidfar M; Quevedo J; Z Réus G; Kim YK
Int J Psychiatry Clin Pract; 2021 Nov; 25(4):407-420. PubMed ID: 33351672
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging.
Wang L; Li K; Zhang Q; Zeng Y; Dai W; Su Y; Wang G; Tan Y; Jin Z; Yu X; Si T
Psychol Med; 2014 May; 44(7):1417-26. PubMed ID: 23942213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
